Viewing Study NCT01522768


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-05-22 @ 12:26 PM
Study NCT ID: NCT01522768
Status: COMPLETED
Last Update Posted: 2023-11-01
First Post: 2012-01-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Sponsor:
Organization: